- Home
- BCRX vs IHS Comparison
BCRX vs IHS Comparison
Compare BCRX & IHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- IHS
- Stock Information
- Founded
- BCRX 1986
- IHS 2001
- Country
- BCRX United States
- IHS United Kingdom
- Employees
- BCRX N/A
- IHS N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- IHS Telecommunications Equipment
- Sector
- BCRX Health Care
- IHS Telecommunications
- Exchange
- BCRX Nasdaq
- IHS Nasdaq
- Market Cap
- BCRX 1.7B
- IHS 1.9B
- IPO Year
- BCRX 1994
- IHS 2021
- Fundamental
- Price
- BCRX $10.09
- IHS $5.77
- Analyst Decision
- BCRX Buy
- IHS Strong Buy
- Analyst Count
- BCRX 8
- IHS 6
- Target Price
- BCRX $16.75
- IHS $9.67
- AVG Volume (30 Days)
- BCRX 3.5M
- IHS 895.1K
- Earning Date
- BCRX 08-04-2025
- IHS 08-12-2025
- Dividend Yield
- BCRX N/A
- IHS N/A
- EPS Growth
- BCRX N/A
- IHS N/A
- EPS
- BCRX N/A
- IHS N/A
- Revenue
- BCRX $503,485,000.00
- IHS $1,733,125,000.00
- Revenue This Year
- BCRX $39.04
- IHS $0.63
- Revenue Next Year
- BCRX $13.26
- IHS $4.82
- P/E Ratio
- BCRX N/A
- IHS N/A
- Revenue Growth
- BCRX 41.67
- IHS N/A
- 52 Week Low
- BCRX $5.92
- IHS $2.44
- 52 Week High
- BCRX $11.31
- IHS $6.30
- Technical
- Relative Strength Index (RSI)
- BCRX 43.54
- IHS 53.28
- Support Level
- BCRX $9.84
- IHS $5.50
- Resistance Level
- BCRX $10.47
- IHS $5.92
- Average True Range (ATR)
- BCRX 0.34
- IHS 0.22
- MACD
- BCRX -0.19
- IHS -0.02
- Stochastic Oscillator
- BCRX 8.16
- IHS 62.75
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About IHS IHS Holding Limited
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, the Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.